| 000 | 01513 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250515100426.0 | ||
| 264 | 0 | _c20080506 | |
| 008 | 200805s 0 0 eng d | ||
| 022 | _a1468-3083 | ||
| 024 | 7 |
_a10.1111/j.1468-3083.2007.02510.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEngin, B | |
| 245 | 0 | 0 |
_aProspective randomized non-blinded clinical trial on the use of dapsone plus antihistamine vs. antihistamine in patients with chronic idiopathic urticaria. _h[electronic resource] |
| 260 |
_bJournal of the European Academy of Dermatology and Venereology : JEADV _cApr 2008 |
||
| 300 |
_a481-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 |
_aDapsone _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFolic Acid Antagonists _xadministration & dosage |
| 650 | 0 | 4 |
_aHistamine H1 Antagonists _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLoratadine _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aStatistics, Nonparametric |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aUrticaria _xdrug therapy |
| 700 | 1 | _aOzdemir, M | |
| 773 | 0 |
_tJournal of the European Academy of Dermatology and Venereology : JEADV _gvol. 22 _gno. 4 _gp. 481-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1468-3083.2007.02510.x _zAvailable from publisher's website |
| 999 |
_c17594849 _d17594849 |
||